~~<i id='A22F5CAA06'><strike id='A22F5CAA06'><tt id='A22F5CAA06'><pre id='A22F5CAA06'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

hotspot

author：entertainment 2025-10-01 02:15:21 - browse：29

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Biden warns of ‘dark winter’ during final presidental debate

Wikipedia

entertainment

focus

leisure time

hotspot

focus

PresidentBidendeliverstheStateoftheUnionaddresstoajointsessionofCongressattheU.S.CapitolonThursday.A

WSS

The battle over 'scope creep' and who gets to be called 'doctor'

Amylyx ALS drug fails large clinical trial

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

What it’s like to watch children die of measles

New lawsuit accuses health insurer Cigna of denying claims in bulk

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

knowledge

hotspot

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

Amylyx ALS drug failure raises questions and concerns

Medicare proposal to cover medical devices draws a mixed reaction

Sen. Paul opposes bill to ban Chinese biotechs

Medical records are filled with copy

What to watch for from Zogenix and Amicus clinical trials

BioMarin wins approval for gene therapy to treat hemophilia A

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Peter Hotez and the public health issue of online harassment

Readout Newsletter: Amylyx, Alto Neuro, and Eli Lilly for the Oscars

entertainment

Will the FTC rein in IQVIA's health data empire?

Headspace, Meta partner to launch VR meditation app for Quest

Change Healthcare cyberattack prompts Medicare loan program

Amylyx ALS drug failure raises questions and concerns

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

'Investigate these claims': UFO transparency at center of House hearing

focus

leisure time

hotspot

focus